Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset

Anand, Sai Priya; Prévost, Jérémie; Nayrac, Manon; Beaudoin-Bussières, Guillaume; Benlarbi, Mehdi; Gasser, Romain; Brassard, Nathalie; Laumaea, Annemarie; Gong, Shang Yu; Bourassa, Catherine; Brunet-Ratnasingham, Elsa; Medjahed, Halima; Gendron-Lepage, Gabrielle; Goyette, Guillaume; Gokool, Laurie; Morrisseau, Chantal; Bégin, Philippe; Martel-Laferrière, Valérie; Tremblay, Cécile; Richard, Jonathan; Bazin, Renée; Duerr, Ralf; Kaufmann, Daniel E.; Finzi, Andrés

With the recent approval of highly effective COVID-19 vaccines, functional and lasting immunity to SARS-CoV-2 is currently under investigation as antibody levels in plasma were shown to decline during convalescence. Since the absence of antibodies does not equate to absence of immune memory, we evaluate the presence of SARS-CoV-2-specific memory B cells in convalescent individuals. Here we report a longitudinal assessment of humoral immune responses on 32 donors up to 8 months post-symptom onset. Our observations indicate that anti-Spike and anti-RBD IgM in plasma decay rapidly, whereas the reduction of IgG is less prominent. Neutralizing activity also declines rapidly when compared to Fc-effector functions. Concomitantly, the frequencies of RBD-specific IgM+ B cells wane significantly when compared to RBD-specific IgG+ B cells which remain stable. Our results add to the current understanding of immune memory following SARS-CoV-2 infection, which is critical for the prevention of secondary infections and vaccine efficacy.